Efferent Labs Issued 6th Patent
(BUFFALO, NY) Feb. 15, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in vivo cellular data, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,246,486…